Ramvansh Fibrology Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 16-11-2024
- Satisfied Charges ₹ 6.75 Cr
as on 16-11-2024
- Revenue -40.67%
(FY 2023)
- Profit -1665.91%
(FY 2023)
- Ebitda -73.21%
(FY 2023)
- Net Worth -51.00%
(FY 2023)
- Total Assets -12.14%
(FY 2023)
About Ramvansh Fibrology
The Corporate was formerly known as Adb Effluent Systems Private Limited. The Company is engaged in the Energy And Power Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹6.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Deepak Garg, Sameer Garg, and Utkarsh Garg serve as directors at the Company.
- CIN/LLPIN
U29253UP2011PTC044239
- Company No.
044239
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ramvansh Fibrology?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Garg  | Director | 04-Apr-2011 | Current |
| Sameer Garg | Director | 04-Apr-2011 | Current |
| Utkarsh Garg | Director | 18-Jun-2014 | Current |
Financial Performance of Ramvansh Fibrology.
Ramvansh Fibrology Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 40.67% decrease. The company also saw a substantial fall in profitability, with a 1665.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ramvansh Fibrology?
In 2023, Ramvansh Fibrology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Dec 2020 | ₹5.00 M | Open |
Union Bank Of India Creation Date: 27 Aug 2015 | ₹2.25 Cr | Satisfied |
Union Bank Of India Creation Date: 21 Aug 2015 | ₹2.25 Cr | Satisfied |
How Many Employees Work at Ramvansh Fibrology?
Unlock and access historical data on people associated with Ramvansh Fibrology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ramvansh Fibrology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramvansh Fibrology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
